The final sample consisted of 188 individuals (89 with SCD and 99 with MCI) who completed FACEHBI v5 or BIOFACE v0 and had OCT-A, brain MRI, amyloid status, and APOE genotype information available. This evidence concerns the gene PLXNA2 and Schnyder corneal dystrophy.